These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6601136)

  • 1. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
    Walker C; Kristensen F; Bettens F; deWeck AL
    J Immunol; 1983 Apr; 130(4):1770-3. PubMed ID: 6601136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation.
    Bettens F; Kristensen F; Walker C; Schwuléra U; Bonnard GD; de Weck AL
    J Immunol; 1984 Jan; 132(1):261-5. PubMed ID: 6606667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of a C3-fragment preparation with IL 2-dependent proliferation.
    Walker C; Kristensen F; Bitter-Suermann D; Stadler BM; de Weck AL
    J Immunol; 1986 May; 136(9):3396-401. PubMed ID: 3082988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
    Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
    Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lymphocyte proliferation. II. Formation of activated (G1) cells.
    Bettens F; Kristensen F; Walker C; de Weck AL
    Eur J Immunol; 1982 Nov; 12(11):948-52. PubMed ID: 6983969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human B cell responsiveness by prostaglandin E2.
    Simkin NJ; Jelinek DF; Lipsky PE
    J Immunol; 1987 Feb; 138(4):1074-81. PubMed ID: 3027169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa.
    Barrera S; Lai J; Fiocchi C; Roche JK
    J Cell Physiol; 1996 Jan; 166(1):130-7. PubMed ID: 8557762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase.
    Beckner SK; Farrar WL
    J Immunol; 1988 Jan; 140(1):208-14. PubMed ID: 2447168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
    Rigby WF; Noelle RJ; Krause K; Fanger MW
    J Immunol; 1985 Oct; 135(4):2279-86. PubMed ID: 2993410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.
    Hernández-Caselles T; Stutman O
    J Immunol; 1993 Oct; 151(8):3999-4012. PubMed ID: 8409382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
    Reiner NE; Finke JH
    J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of macrophages on the go-gl and gl-S transition of thymocytes.
    Bettens F; Kristensen F; DeWeck AL
    Immunology; 1982 Feb; 45(2):199-205. PubMed ID: 6800937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
    Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
    Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.